Catalent Pharma Solutions

John Chiminski has been appointed president and chief executive officer, Catalent Pharma Solutions, effective March 17th. George Fotiades, who has held this position on an interim basis, will step down, but will continue to serve as chairman of the board of directors. Mr. Chiminski will also serve as a member of the board.                                   

Mr. Chiminski most recently served as the president and chief executive officer of GE Medical Diagnostics. During his 21 years at GE, Mr. Chiminski held senior management positions of increasing responsibility in a number of businesses, and contributed to new product innovation, operational performance improvements, and global growth.  

George Fotiades said, “I am pleased to welcome John to the Catalent executive team.  He is an exceptional leader with a passion for serving the customer.  His proven track record in innovation, operational excellence and achieving superior performance with global businesses is ideally suited to driving Catalent to reach its full potential.”

“I’m thrilled to be joining Catalent, a great business with a history of innovation and service excellence,” said Mr. Chiminski.  “Catalent has unique technologies, a strong market position, and highly committed people around the world. I look forward to working with the Catalent team to extend these advantages to meet the growing needs of our customers.”